die news mit der spende ist doch sch. egal...ist ne nette geste...
die news tags zuvor ist viel wichtiger:
Emergency Filtration Products -- EFP -- Enters Into Long-Term Distribution Agreement with Itochu Techno Chemical for EFP`s RespAide, Vapor Isolation Valve and Series One Breathing Circuit Filter Products
Tuesday December 28, 6:00 am ET
Itochu Techno Chemical and EFP Consider Expanding Distribution Agreement to Include EFP`s Emergency Resuscitation ELVIS Product
HENDERSON, Nev.--(BUSINESS WIRE)--Dec. 28, 2004-- Emergency Filtration Products, Inc. (EFP) (OTCBB:EMFP - News) today announced that it has entered into an exclusive, long term importation agreement with its partner, Itochu Techno Chemical Inc. whereby Itochu will distribute the company`s RespAide, Vapor Isolation Valve and Series One Breathing Circuit Filter products in Japan.
ADVERTISEMENT
The term of the agreement commenced on December 1, 2004, terminates on May 1, 2008, but can be extended for an additional three-year period: both partners expect that it will be extended well past 2011 in subsequent agreements. The agreement also allows for Itochu to form sub-distribution agreements with other medical products companies (with EFP`s approval) to promote the sale of EFP`s products in Japan.
Commencing immediately, Itochu, in conjunction with its partner/affiliate Senko Medical Instrument Mfg. Co. Ltd., one of Japan`s leading medical products distributors, will conduct a marketing review over the next several months. The marketing review period is required by Koseisho (Ministry of Health and Welfare, similar to the U.S. FDA) and mandates that companies who have been granted a Certificate of Import and a Certificate of Sale comply fully with Japanese regulations concerning medical products.
As part of this marketing review, Itochu will immediately place an initial order for EFP`s products to introduce the products; to develop interest in the products; and, to create a market for the products in Japan. In addition, Itochu will have the right to purchase additional products from EFP during the marketing review period under the same terms and conditions that govern the initial order.
The marketing review will enable Itochu to make initial introductions of the products to potential customers in Japan; to determine the potential size of the market in Japan; and, to allow the parties to establish minimum purchase requirement quantities applicable to this agreement for each annual period commencing on June 1, 2005.
"We are delighted to have formalized our partnership with Itochu and to have our products introduced to the Japanese market, the second largest medical products market in the world," said Douglas K. Beplate, President, EFP. "We are highly confident that with Itochu`s and Senko`s leadership, we will be able to establish a solid sales channel that will be viable for many years." Mr. Beplate went on to say, "And, with Itochu leading the way, EFP is likely to be able to expand the number of product offerings that it makes in Japan, and eventually, in other Asian countries."
Separately, the company announced that EFP and Itochu will also collaborate on obtaining Koseisho approval for the company`s ELVIS product. ELVIS (Emergency Life Support Ventilation and Intubation System) is a self-contained device that delivers medicine in aerosol form and a bag with built-in CO(2) monitoring capabilities. Patents have been granted for this product and the company has executed an agreement whereby it acquired the rights for commercial exploitation of the patents.
